CCL2 and Familial prostate cancer: In vitro studies of prostate cancer reported that monocyte-induced cancer cell invasion mediates chemokine ligand 2 (monocyte chemotactic protein-1) and nuclear factor-κB activity [16] and that tumor stroma-derived factors skew monocyte to dendritic cell differentiation toward a suppressive phenotype [17].